US FDA's top vaccine official Vinay Prasad leaves agency after 3 months
Prasad, an oncologist who was a fierce critic of U.S. COVID-19 vaccine and mask mandates, had been appointed in May by FDA Commissioner Marty Makary. Together they had promised to speed regulatory action and pilot new review pathways.
In recent days, criticism of his tenure has intensified around the agency's handling of a gene therapy for Duchenne muscular dystrophy from Sarepta Therapeutics (SRPT.O), opens new tab.
The FDA-approved therapy played a role in the death of two teens who had advanced disease, and after a third death in a separate experimental gene therapy from the company, the FDA on July 18 asked Sarepta to stop all shipments of the approved DMD therapy, saying it had safety concerns.
Laura Loomer, a far-right activist and President Donald Trump ally, on July 20 posted a blog in which she called Prasad a "progressive leftist saboteur" who was undermining the agency's work. Loomer critiques earlier this year led to the ouster of national security officials.
On Monday, the Wall Street Journal's opinion section ran two pieces criticizing Prasad, one of which called him a Bernie Sanders acolyte in MAHA drag, referring to the Trump administration's "Make America Healthy Again" movement. Both said he was not basing regulatory decisions on whether drugs helped patients, but on price.
"When he saw some of these sort of smear pieces, he didn't want to be a distraction," Makary said of Prasad's departure in an interview with CNBC on Wednesday.
Prasad, whose departure was announced late on Tuesday, did not immediately respond to a request for comment.
The FDA on Monday changed course on Sarepta and said shipments to the main group of patients for the drug could restart.
Other changes under Prasad, who was also the agency's chief medical and science officer, included a new policy limiting the approval for COVID-19 vaccines, and his FDA division also rejected therapies from Replimmune (REPL.O), opens new tab and Capricor Therapeutics (CAPR.O), opens new tab.
Shares of Replimmune nearly doubled in value, while those of Sarepta and Capricor gained 11% and 18%, respectively on Wednesday.
Endpoints and STAT news first reported Prasad's departure.
Prasad was a physician who joined the agency from the University of California, San Francisco. He has had stints at the National Cancer Institute and the National Institutes of Health.
The Department of Health and Human Services, which oversees the FDA, did not immediately respond to a request for comment on when Prasad's successor could be announced.
The FDA and other health agencies have seen multiple shakeups in recent months, under the leadership of U.S. Health Secretary Robert F. Kennedy Jr.
Prasad's predecessor and longtime vaccine official at the FDA, Peter Marks, was ousted earlier this year, followed by gene therapy head Nicole Verdun.
"While another vacancy and another potential new face add uncertainty, we still think Prasad's departure is a net positive for the sector as many of our conversations have been overwhelmingly focused on regulatory risk and what he may or may
not do," said Leerink analyst Joseph Schwartz.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
a minute ago
- The Independent
AMA and other medical associations are kicked out of CDC vaccine workgroups
U.S. health officials have told more than a half-dozen of the nation's top medical organizations that they will no longer help establish vaccination recommendations. The government told the organizations on Thursday via email that their experts are being disinvited from the workgroups that have been the backbone of the Advisory Committee on Immunization Practices. The organizations include the American Medical Association, the American Academy of Pediatrics and the Infectious Diseases Society of America. 'I'm concerned and distressed,' said Dr. William Schaffner, a Vanderbilt University vaccine expert who for decades has been involved with ACIP and its workgroups. He said the move will likely propel a confusing fragmentation of vaccine guidance, as patients may hear the government say one thing and hear their doctors say another. One email said the organizations are 'special interest groups and therefore are expected to have a 'bias' based on their constituency and/or population that they represent.' A federal health official on Friday confirmed the action, which was first reported by Bloomberg. The decision was the latest development in what has become a saga involving the ACIP. The committee, created in 1964, makes recommendations to the Centers for Disease Control and Prevention on how vaccines that have been approved by the Food and Drug Administration should be used. CDC directors have traditionally almost always approved those recommendations, which are widely heeded by doctors and greenlight insurance coverage for shots. U.S. Health Secretary Robert F. Kennedy Jr. was a leading voice in the anti-vaccine movement before becoming the U.S. government's top health official, and in June abruptly fired the entire ACIP after accusing them of being too closely aligned with manufacturers. He handpicked replacements that include several vaccine skeptics. The workgroups typically include committee members and experts from medical and scientific organizations. At workgroup meetings, members evaluate data from vaccine manufacturers and the CDC, and formulate vaccination recommendation proposals to be presented to the full committee. The structure was created for several reasons, Schaffner said. The professional groups provide input about what might and might not be possible for doctors to implement. And it helped build respect and trust in ACIP recommendations, having the buy-in of respected medical organizations, he said. Workgroup members are vetted for conflicts of interest, to make sure than no one who had, say, made money from working on a hepatitis vaccine was placed on the hepatitis committee, Schaffner noted. Also disinvited from the groups were the American Academy of Family Physicians, the American College of Physicians, the American Geriatrics Society, the American Osteopathic Association, the National Medical Association and the National Foundation for Infectious Diseases. In a joint statement Friday, the AMA and several of the other organizations said: 'To remove our deep medical expertise from this vital and once transparent process is irresponsible, dangerous to our nation's health, and will further undermine public and clinician trust in vaccines.' They urged the administration to reconsider the move "so we can continue to feel confident in its vaccine recommendations for our patients.' Some of the professional organizations have criticized Kennedy's changes to the ACIP, and three of the disinvited groups last month joined a lawsuit against the government over Kennedy's decision to stop recommending COVID-19 vaccines for most children and pregnant women. In a social media post Friday, one of the Kennedy-appointed ACIP members — Retsef Levi — wrote that the working groups 'will engage experts from even broader set of disciplines!' Levi, a business management professor, also wrote that working group membership 'will be based on merit & expertise — not membership in organizations proven to have (conflicts of interest) and radical & narrow view of public health!' HHS officials have not said which people are going to be added to the ACIP workgroups. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Reuters
2 minutes ago
- Reuters
Trump orders nuclear submarines moved after Russian 'provocative statements'
WASHINGTON, Aug 1 (Reuters) - U.S. President Donald Trump on Friday said he had ordered two nuclear submarines to be positioned in "the appropriate regions" in response to statements from former Russian President Dmitry Medvedev. "Based on the highly provocative statements of the Former President of Russia, Dmitry Medvedev ... I have ordered two Nuclear Submarines to be positioned in the appropriate regions, just in case these foolish and inflammatory statements are more than just that," Trump said in a social media post. He added: "Words are very important, and can often lead to unintended consequences, I hope this will not be one of those instances." He did not specify what he meant by "nuclear submarines." Submarines may be nuclear-powered, or armed with nuclear missiles. It is extremely rare for the U.S. military to discuss the deployment and location of U.S. submarines given their sensitive mission in nuclear deterrence. The U.S. Navy declined comment. The Pentagon did not immediately respond to a request for comment. Trump and Medvedev, who is deputy chairman of Russia's Security Council, have traded taunts in recent days after Trump on Tuesday said Russia had "10 days from today" to agree to a ceasefire in Ukraine or be hit with tariffs, along with its oil buyers. Medvedev on Thursday said Trump should remember that Moscow possessed Soviet-era nuclear strike capabilities of last resort, after Trump told Medvedev to "watch his words." Moscow, which has set out its own terms for peace in Ukraine, has given no indication that it will comply with Trump's deadline of August 8. Russian President Vladimir Putin said on Friday that Moscow hoped for more peace talks with Ukraine but that the momentum of the war was in its favor. He made no reference to the deadline. Trump, who in the past touted good relations with Putin, has expressed mounting frustration with the Russian leader, accusing him of "bullshit" and describing Russia's latest attacks on Ukraine as disgusting. Medvedev has emerged as one of the Kremlin's most outspoken anti-Western hawks since Russia sent tens of thousands of troops into Ukraine in 2022. Kremlin critics deride him as an irresponsible loose cannon, though some Western diplomats say his statements illustrate the thinking in senior Kremlin policy-making circles. Trump also rebuked Medvedev in July, accusing him of throwing around the "N (nuclear) word" after the Russian official criticized U.S. strikes on Iran and said "a number of countries" were ready to supply Iran with nuclear warheads. "I guess that's why Putin's 'THE BOSS'", Trump said at the time. The U.S. president took office in January having promised to end the Ukraine war on Day One, but has not been able to get Moscow to agree to a ceasefire. Only six countries operate nuclear-powered submarines: the U.S., the UK, Russia, China, France and India. The U.S. Navy has 71 commissioned submarines including 53 fast attack submarines, 14 ballistic-missile submarines, and four guided-missile submarines. All of them are nuclear-powered, but only some carry nuclear weapon-tipped missiles.
Reuters
2 minutes ago
- Reuters
Second US appeals court open to blocking Trump's birthright citizenship order
Aug 1 (Reuters) - U.S. President Donald Trump's order restricting birthright citizenship appeared on Friday to be headed toward being declared unconstitutional by a second federal appeals court, as judges expressed deep skepticism about a key piece of his hardline immigration agenda. A three-judge panel of the Boston-based 1st U.S. Circuit Court of Appeals sharply questioned a lawyer with the U.S. Department of Justice as to why they should overturn two lower-court judges who blocked the order from taking effect. Those lower-court judges include one in Boston who last week reaffirmed his prior decision to block the order's enforcement nationally, even after the U.S. Supreme Court in June curbed the power of judges to broadly enjoin that and other policies. The San Francisco-based 9th U.S. Circuit Court of Appeals last week became the first federal appeals court to hold Trump's order is unconstitutional. Its ultimate fate will likely be determined by the U.S. Supreme Court. Justice Department attorney Eric McArthur said on Friday that the citizenship clause of the U.S. Constitution's 14th Amendment, which was ratified in 1868 after the U.S. Civil War, rightly extended citizenship to the children of newly-freed enslaved Black people. "It did not extend birthright citizenship as a matter of constitutional right to the children of aliens who are present in the country temporarily or unlawfully," he said. But the judges questioned how that argument was consistent with the Supreme Court's 1898 ruling interpreting the clause in United States v. Wong Kim Ark, long understood as guaranteeing American citizenship to children born in the U.S. to non-citizen parents. "We have an opinion by the Supreme Court that we aren't free to disregard," said Chief U.S. Circuit Judge David Barron, who like his two colleagues was appointed by a Democratic president. Trump's executive order, issued on his first day back in office on January 20, directs agencies to refuse to recognize the citizenship of U.S.-born children who do not have at least one parent who is an American citizen or lawful permanent resident, also known as a "green card" holder. Every court to consider the order's merits has declared it unconstitutional, including the three judges who halted the order's enforcement nationally. Those judges included U.S. District Judge Leo Sorokin in Boston, who ruled in favor of 18 Democratic-led states and the District of Columbia, who had swiftly challenged Trump's policy in court. "The Supreme Court has repeatedly recognized children born to individuals who are here unlawfully or who are here on a temporary basis are nonetheless birthright citizens," Shankar Duraiswamy, a lawyer for New Jersey, argued on Friday. The 6-3 conservative majority U.S. Supreme Court on June 27 sided with the administration in the litigation by restricting the ability of judges to issue so-called universal injunctions and directing lower courts that had blocked Trump's policy nationally to reconsider the scope of their orders. But the ruling contained exceptions, allowing federal judges in Massachusetts and New Hampshire and the 9th Circuit to issue new decisions stopping Trump's order from taking effect nationally. The rulings on appeal to the 1st Circuit were issued by Sorokin and the New Hampshire judge, who originally issued a narrow injunction but more recently issued a new decision in a recently-filed class action blocking Trump's order nationwide.
